Leadership Overview
Bliss GVS Pharma has 5 executives leading key functions including financial strategy, global marketing, production coordination, and market expansion.
Committed to enhancing global well-being, Bliss GVS Pharma drives pharmaceutical accessibility through the manufacturing of high-quality suppositories, pessaries, and diverse healthcare solutions for international markets.
Committed to enhancing global well-being, Bliss GVS Pharma drives pharmaceutical accessibility through the manufacturing of high-quality suppositories, pessaries, and diverse healthcare solutions for international markets.
Leadership Roles at Bliss GVS Pharma
Deepak Sawant - Chief Financial Officer
Deepak Sawant, the Chief Financial Officer at Bliss GVS Pharma, directs all fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while managing the budgetary requirements for global manufacturing facilities. This leadership role involves optimizing cost structures for the production of capsules, creams, and injections to maintain competitive market positioning. By analyzing revenue streams across diverse geographic regions, Deepak Sawant directly impacts the long-term growth trajectory of the company. The Chief Financial Officer coordinates with the board to secure funding for facility upgrades, thereby supporting the mission of increasing pharmaceutical accessibility. Through disciplined fiscal oversight, Sawant secures the financial stability necessary for sustained innovation in the pharmaceutical sector, ensuring that resources align with the overarching goal of delivering effective healthcare solutions to consumers worldwide.
Vidula Ranade - Executive- Chief Marketing Officer
Vidula Ranade, the Executive- Chief Marketing Officer at Bliss GVS Pharma, architects the global brand strategy and market penetration initiatives. Overseeing the promotion of the extensive product portfolio, the Executive- Chief Marketing Officer ensures that healthcare providers recognize the efficacy of the company's suppositories and pessaries. This leadership role involves identifying emerging market opportunities across international territories to expand the reach of pharmaceutical offerings. By crafting targeted campaigns, Vidula Ranade directly influences consumer trust and brand loyalty in competitive healthcare landscapes. The Executive- Chief Marketing Officer collaborates with regional sales teams to tailor messaging that addresses specific medical needs, thereby driving demand for the company's specialized manufacturing output. Through strategic market positioning, Ranade strengthens the presence of the organization, ensuring that the mission of rediscovering pharmaceutics remains central to all external communications and outreach efforts conducted by the marketing department.
Vijay Dalavi - Executive Chief Marketing Officer & Production Coordinator
Vijay Dalavi, the Executive Chief Marketing Officer & Production Coordinator at Bliss GVS Pharma, synchronizes marketing demand with manufacturing output. Overseeing the alignment between supply chain capabilities and market requirements, the Executive Chief Marketing Officer & Production Coordinator ensures that production schedules meet the high-volume needs for global healthcare distribution. This leadership role involves optimizing the manufacturing flow for injections and healthcare items to maximize efficiency and quality. By bridging the gap between product availability and market demand, Vijay Dalavi directly impacts the operational success of the company. The Executive Chief Marketing Officer & Production Coordinator manages cross-functional workflows to ensure that manufacturing facilities operate at peak performance levels. Through meticulous coordination, Dalavi supports the company's commitment to accessibility, ensuring that essential pharmaceutical products reach healthcare providers and consumers with consistency and reliability across all served international markets.
Sampat Jondhale - Manager Chief Marketing Officer
Sampat Jondhale, the Manager Chief Marketing Officer at Bliss GVS Pharma, executes tactical marketing programs focused on regional market development. Overseeing the implementation of localized promotional strategies, the Manager Chief Marketing Officer ensures that the company's pharmaceutical solutions gain traction within specific healthcare segments. This leadership role involves analyzing regional market data to refine outreach efforts for capsules and creams. By managing the day-to-day execution of marketing initiatives, Sampat Jondhale directly supports the broader goal of increasing pharmaceutical accessibility. The Manager Chief Marketing Officer coordinates with field representatives to gather insights that inform future product positioning and service enhancements. Through consistent engagement with healthcare providers, Jondhale drives the adoption of the company's specialized products, ensuring that the brand remains a preferred choice for effective healthcare solutions while contributing to the overall growth and market impact of the organization.
Aditi More - Senior Executive, Chief Marketing Officer
Aditi More, the Senior Executive, Chief Marketing Officer at Bliss GVS Pharma, drives strategic partnerships and high-level market expansion initiatives. Overseeing the development of long-term relationships with major healthcare distributors, the Senior Executive, Chief Marketing Officer ensures that the company's manufacturing output reaches critical mass in key international markets. This leadership role involves negotiating complex agreements that facilitate the widespread availability of suppositories and pessaries. By fostering these essential connections, Aditi More directly impacts the company's ability to scale operations and enhance global well-being. The Senior Executive, Chief Marketing Officer collaborates with the executive team to align marketing strategies with the company's mission of rediscovering pharmaceutics. Through visionary leadership, More secures the market position of the organization, ensuring that the company remains at the forefront of the pharmaceutical industry by consistently delivering high-quality, accessible healthcare solutions to diverse populations.
Explore Leadership Teams in Manufacturing
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
CC
SR
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines.
Company Leadership
HA
AS
MB
Frequently Asked Questions Regarding Bliss GVS Pharma Top Executives and Leadership Team
